Shuichi Miyawaki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis.
Journal: Therapeutic advances in hematology
Published: September 04, 2025
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia.
Journal: International journal of hematology
Published: January 03, 2024
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
Journal: Blood cancer discovery
Published: October 18, 2021
Efficacy and safety of Wilms' tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial.
Journal: Cancer immunology, immunotherapy : CII
Published: May 20, 2021
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.
Journal: International journal of clinical oncology
Published: April 30, 2021
Multiple Cysts Formation in Pulmonary Light Chain Deposition Disease(LCDD)-A Case Report
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 20, 2021
Timely Diagnosis and Successful Treatment of Intravascular Large B-Cell Lymphoma in an Elderly Patient with Poor Performance Status.
Journal: The American journal of case reports
Published: June 04, 2019
Familial case of hereditary Pelger-Huët anomaly.
Journal: International journal of hematology
Published: May 08, 2019
Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia.
Journal: International journal of hematology
Published: December 11, 2018
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
Journal: Annals of hematology
Published: August 05, 2018
Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.
Journal: Blood advances
Published: April 02, 2018
Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study.
Journal: Cancer science
Published: March 22, 2018
Last Updated: 09/26/2026